NCT00590161View on ClinicalTrials.gov

Pentoxifylline in Patients With Nonalcoholic Steatohepatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

July 31, 2010

Study Completion Date

December 31, 2010

Conditions
Nonalcoholic Steatohepatitis
Interventions
DRUG

pentoxifylline (PTX)

400 mg PO tid

DRUG

placebo

placebo tid

Trial Locations (3)

44106

Louis Stokes VA Medical Center, Cleveland

44109

Metrohealth Medical Center, Cleveland

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
collaborator

American College of Gastroenterology

OTHER

lead

Case Western Reserve University

OTHER

NCT00590161 - Pentoxifylline in Patients With Nonalcoholic Steatohepatitis | Biotech Hunter | Biotech Hunter